Greenwich LifeSciences Stock (NASDAQ: GLSI) stock price, news, charts, stock research, profile.
Open | $14.440 |
Close | - |
Volume / Avg. | 3.675K / 52.636K |
Day Range | 14.290 - 14.590 |
52 Wk Range | 7.580 - 21.440 |
Market Cap | $187.445M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 2.3% |
Days to Cover | 4.02 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Greenwich LifeSciences (NASDAQ: GLSI) through any online brokerage.
Other companies in Greenwich LifeSciences’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT), bluebird bio (NASDAQ:BLUE) and Atossa Therapeutics (NASDAQ:ATOS).
The latest price target for Greenwich LifeSciences (NASDAQ: GLSI) was reported by HC Wainwright & Co. on Wednesday, February 28, 2024. The analyst firm set a price target for 36.00 expecting GLSI to rise to within 12 months (a possible 147.34% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Greenwich LifeSciences (NASDAQ: GLSI) is $14.555 last updated Today at May 6, 2024 at 11:19 AM EDT.
There are no upcoming dividends for Greenwich LifeSciences.
Greenwich LifeSciences’s Q1 earnings are confirmed for Monday, May 20, 2024.
There is no upcoming split for Greenwich LifeSciences.
Greenwich LifeSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.